GlassScriptPhysician profile
Elisa Stauffer
NPI 1083811962
$1,874.40
in general payments reported to CMS, 2019-2025
8 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Pediatric Hematology-Oncology provider received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $23.70 · 2021: $1,538 · 2022: $18.32 · 2023: $158 · 2024: $31.09 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206 · Consulting Fee: $89.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $205.76 |
| Consulting Fee | $89.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $1,433.52 | 2021-2023 | Nuwiq |
| Emmaus Medical, INC. | $250.79 | 2020-2023 | Endari |
| Cranial Technologies, INC | $88.35 | 2024-2025 | Doc Band |
| Sanofi-Aventis U.S. LLC | $29.72 | 2023 | |
| Novartis Pharmaceuticals Corporation | $23.61 | 2021 | |
| Uswm, LLC | $16.77 | 2024 | Iwilfin |
| Rare Disease Therapeutics, INC. | $16.66 | 2025 | Xromi |
| Alexion Pharmaceuticals, INC. | $14.98 | 2025 | Strensiq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elisa Stauffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.